Page last updated: 2024-11-05

trihexyphenidyl and Dermatitis, Seborrheic

trihexyphenidyl has been researched along with Dermatitis, Seborrheic in 1 studies

Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.

Dermatitis, Seborrheic: A chronic inflammatory disease of the skin with unknown etiology. It is characterized by moderate ERYTHEMA, dry, moist, or greasy (SEBACEOUS GLAND) scaling and yellow crusted patches on various areas, especially the scalp, that exfoliate as dandruff. Seborrheic dermatitis is common in children and adolescents with HIV INFECTIONS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sandyk, R1

Other Studies

1 other study available for trihexyphenidyl and Dermatitis, Seborrheic

ArticleYear
Alpha-melanocyte-stimulating hormone: possible role in the pathophysiology of acute drug-induced dystonia.
    The International journal of neuroscience, 1990, Volume: 53, Issue:2-4

    Topics: alpha-MSH; Child; Dermatitis, Seborrheic; Dyskinesia, Drug-Induced; Female; Humans; Hydroxyzine; Mov

1990